Ceftriaxone IV Dosing and Formulation
For adults, administer ceftriaxone 1-2 grams IV once daily (or divided every 12 hours) with a maximum of 4 grams per day; for pediatric patients, use 50-75 mg/kg/day (up to 100 mg/kg/day for meningitis), with neonates requiring special considerations including 60-minute infusions to reduce bilirubin encephalopathy risk. 1
Adult Dosing
Standard Infections
- Usual dose: 1-2 grams IV once daily or divided every 12 hours 1
- Maximum daily dose: 4 grams 1
- Duration: Continue for at least 2 days after signs/symptoms resolve; typical duration 4-14 days 1
Specific Conditions
For meningitis in adults, the UK guideline recommends 2 grams IV every 12 hours 2. For community-acquired pneumonia, recent evidence suggests 1 gram daily may be sufficient in regions with low penicillin-resistant Streptococcus pneumoniae prevalence 3, though 2 grams daily remains standard for severe cases requiring mechanical ventilation 4.
For uncomplicated gonococcal infections, use a single 250 mg IM dose 1. For surgical prophylaxis, administer 1 gram IV 30 minutes to 2 hours before surgery 1.
Renal/Hepatic Impairment
No dosage adjustment is necessary for renal or hepatic impairment alone 1. However, recent pharmacokinetic data suggests patients with eGFR >60 mL/min/1.73 m² may benefit from twice-daily dosing (1 gram every 12 hours) rather than once-daily regimens 5.
Pediatric Dosing
By Indication
Skin and soft tissue infections: 50-75 mg/kg once daily or divided every 12 hours (maximum 2 grams/day) 1
Serious infections (non-meningitis): 50-75 mg/kg/day divided every 12 hours (maximum 2 grams/day) 1
Meningitis:
- Initial dose: 100 mg/kg (maximum 4 grams) 1
- Maintenance: 100 mg/kg/day once daily or divided every 12 hours (maximum 4 grams/day) 1
- Duration: 7-14 days 1
Recent pharmacokinetic modeling suggests once-daily dosing (100 mg/kg) achieves superior CSF penetration compared to twice-daily regimens for meningitis, with 88% probability of target attainment at 24 hours versus 53% for divided dosing 6.
Acute otitis media: Single IM dose of 50 mg/kg (maximum 1 gram) 1
Bacteremia/arthritis: 50 mg/kg once daily (maximum 1 gram for <45 kg; no maximum for ≥45 kg) for 7 days 1
Specific Pediatric Guidelines
For endocarditis caused by gram-negative enteric bacilli or HACEK organisms, use 100 mg/kg/day divided every 12 hours OR 80 mg/kg/day once daily (maximum 4 grams/day) 7.
For complicated intra-abdominal infections, ceftriaxone can be combined with metronidazole at standard pediatric doses 8.
Neonatal Dosing
Critical Safety Considerations
CONTRAINDICATED in neonates receiving IV calcium-containing solutions due to fatal precipitation risk 1. Also contraindicated in hyperbilirubinemic neonates, especially premature infants 1.
Dosing by Age and Weight
≤7 days postnatal age:
>7 days postnatal age:
Infusion time: Administer over 60 minutes in neonates to reduce bilirubin encephalopathy risk 1
For disseminated gonococcal infection or meningitis in neonates: 25-50 mg/kg/day IV/IM once daily for 7 days (10-14 days if meningitis documented) 10, 11
IV Administration and Formulation
Reconstitution for IV Use
Vial preparation 1:
- 250 mg vial: Add 2.4 mL diluent
- 500 mg vial: Add 4.8 mL diluent
- 1 gram vial: Add 9.6 mL diluent
- 2 gram vial: Add 19.2 mL diluent
After reconstitution, each 1 mL contains approximately 100 mg ceftriaxone 1.
Infusion Parameters
Concentration: 10-40 mg/mL recommended (lower concentrations acceptable) 1
Infusion duration:
Compatible Diluents
Approved diluents 1:
- Sterile Water for Injection
- 0.9% Sodium Chloride
- 5% Dextrose in Water (D5W)
- 10% Dextrose
- 5% Dextrose + 0.9% Sodium Chloride
- 5% Dextrose + 0.45% Sodium Chloride
DO NOT USE calcium-containing diluents (Ringer's solution, Hartmann's solution) - particulate formation will occur 1
Incompatibilities
Never mix with 1:
- Vancomycin
- Aminoglycosides (gentamicin, tobramycin, amikacin)
- Amsacrine
- Fluconazole
If these drugs must be given, administer sequentially with thorough line flushing between administrations 1.
Compatible with metronidazole at concentrations ≤5-7.5 mg/mL metronidazole with ceftriaxone 10 mg/mL; stable 24 hours at room temperature in 0.9% NaCl or D5W only 1
Stability
Room temperature (25°C) 1:
- Reconstituted solutions: 2 days in most diluents
- Concentrations 10-40 mg/mL: 2 days
Refrigerated (4°C) 1:
- Most diluent combinations: 10 days
- 5% Dextrose + 0.9% or 0.45% Sodium Chloride: Incompatible when refrigerated
Frozen (-20°C): Stable 26 weeks in PVC or polyolefin containers; thaw at room temperature, do not refreeze 1
Key Clinical Pitfalls
Neonatal calcium interaction: This is potentially fatal - always verify no concurrent IV calcium before administering to neonates 1
Infusion duration in neonates: The 60-minute infusion is not optional - rapid infusion increases bilirubin encephalopathy risk 1
Once vs. twice daily dosing: For meningitis, once-daily dosing appears superior for CSF penetration 6; for severe pneumonia with mechanical ventilation, twice-daily may improve mortality 4
Augmented renal clearance: Patients with eGFR >60 mL/min/1.73 m² may require twice-daily dosing for adequate exposure 5
Line compatibility: Flush lines thoroughly between ceftriaxone and incompatible drugs - precipitation can occur rapidly 1